Skip to main content
SpringerLink
Log in

Interrogating the Activity of Ligands at Monoamine Transporters in Rat Brain Synaptosomes

  • Protocol
  • First Online:
Neurotransmitter Transporters

Part of the book series: Neuromethods ((NM,volume 118))

Abstract

The plasma membrane transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT) are the main sites of action for therapeutic and abused stimulant drugs. As a means to identify novel medications for stimulant addiction and other psychiatric disorders, we developed in vitro assays in rat brain tissue that can be used to determine structure–activity relationships for test compounds at these monoamine transporters. Uptake inhibition assays measure the ability of drugs to block the transporter-mediated uptake of [3H]neurotransmitters into synaptosomes, whereas release assays measure the ability of drugs to serve as transporter substrates that evoke efflux (i.e., release) of [3H]neurotransmitters from synaptosomes by reverse transport. These assays can be used to rapidly determine the potency of test compounds at DAT, NET, and SERT under similar conditions, establishing the selectivity of drugs across all three transporters. The combined results from uptake and release assays can discriminate whether a compound is a transporter inhibitor or substrate (i.e., releaser). Our assay procedures have been used to characterize the molecular mechanism of action for older amphetamine-type medications and newer transporter ligands with therapeutic potential. The data from these assays can also predict the addictive and neurotoxic properties of abused stimulants. Information provided by these assays continues to provide insight into monoamine transporter structure and function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gorman JM, Kent JM (1999) SSRIs and SMRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry 60(Suppl 4):33–38

    PubMed  Google Scholar 

  2. Iversen L (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147(Suppl 1):S82–S88

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Rothman RB et al (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32–41

    Article  CAS  PubMed  Google Scholar 

  4. Howell LL, Kimmel HL (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75:196–217

    Article  CAS  PubMed  Google Scholar 

  5. Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23–40

    Article  CAS  PubMed  Google Scholar 

  6. Sitte HH, Freissmuth M (2015) Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 36:41–50

    Article  CAS  PubMed  Google Scholar 

  7. Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189:407–424

    Article  CAS  Google Scholar 

  8. Fleckenstein AE et al (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681–698

    Article  CAS  PubMed  Google Scholar 

  9. Gray EG, Whittaker VP (1962) The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96:79–88

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Wilhelm BG et al (2014) Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344:1023–1027

    Article  CAS  PubMed  Google Scholar 

  11. Rothman RB et al (1993) Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34–39

    Article  CAS  PubMed  Google Scholar 

  12. Rothman RB et al (2015) Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency. J Pharmacol Exp Ther 353(3):529–538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rothman RB et al (2000) Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction. Ann N Y Acad Sci 914:71–81

    Article  CAS  PubMed  Google Scholar 

  14. Baumann MH et al (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38(4):552–562

    Article  CAS  PubMed  Google Scholar 

  15. Rudnick G, Clark J (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144:249–263

    Article  CAS  PubMed  Google Scholar 

  16. Rothman RB, Baumann MH (2006) Therapeutic potential of monoamine transporter substrates. Curr Top Med Chem 6:1845–1859

    Article  CAS  PubMed  Google Scholar 

  17. Rothman RB et al (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307:138–145

    Article  CAS  PubMed  Google Scholar 

  18. Scholze P et al (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter. J Pharmacol Exp Ther 293:870–878

    CAS  PubMed  Google Scholar 

  19. Rothman RB et al (2003) (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. J Pharmacol Exp Ther 305:1191–1199

    Article  CAS  PubMed  Google Scholar 

  20. Yu H et al (2000) Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg Med Chem 8:2689–2692

    Article  CAS  PubMed  Google Scholar 

  21. Rothman RB et al (2012) Studies of the biogenic amine transporters. 14. Identification of low-efficacy “partial” substrates for the biogenic amine transporters. J Pharmacol Exp Ther 341(1):251–262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Baumann MH et al (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in the brain. Neuropsychopharmacology 37(5):1192–1203

    Article  CAS  PubMed  Google Scholar 

  23. Saha K et al (2015) ‘Second-generation’ mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40(6):1321–1331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Marusich JA et al (2014) Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206–213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bonano JS et al (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172(10):2433–2444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sakloth F et al (2015) Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172(9):2210–2218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA

    John S. Partilla & Richard B. Rothman

  2. Medicinal Chemistry Section, IRP, NIDA, NIH, 333 Cassell Drive, Suite 4400, Baltimore, MD, 21224, USA

    Michael H. Baumann Ph.D.

  3. Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, 27709, USA

    Ann M. Decker & Bruce E. Blough

Authors
  1. John S. Partilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael H. Baumann Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ann M. Decker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruce E. Blough
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard B. Rothman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael H. Baumann Ph.D. .

Editor information

Editors and Affiliations

  1. Biomedical Center Institute of Pharmacology and Toxicology, University of Bonn, Bonn, Germany

    Heinz Bönisch

  2. Center of Physiology and Pharmacology Institute of Pharmacology, Medical University of Vienna, Vienna, Austria

    Harald H. Sitte

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Partilla, J.S., Baumann, M.H., Decker, A.M., Blough, B.E., Rothman, R.B. (2016). Interrogating the Activity of Ligands at Monoamine Transporters in Rat Brain Synaptosomes. In: Bönisch, H., Sitte, H. (eds) Neurotransmitter Transporters. Neuromethods, vol 118. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3765-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3765-3_3

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3763-9

  • Online ISBN: 978-1-4939-3765-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation